New Blood Test to Help Physicians Prevent Major Cardiovascular Events in Women with Lupus
Heart Disease Blood Test
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Now, a genetic precision medicine test for lupus patients could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies.
Researchers have identified shared genetic risk factors for systemic lupus erythematosus and coronary artery disease, according to data published in Cell Reports Medicine.
Ampel Bio-Solutions is working on a blood test that can find out if a person carries traits that may put them at higher risk of developing heart disease.
The CardioGENE lab test identifies inherited genetic markers in blood samples which drive pathways to prevent cardiovascular issues with prophylactic targeted treatment
You won’t find test tubes or chemicals at Ampel Biosolutions. Instead, the company uses computers to study huge amounts of medical information – to identify genes responsible for auto-immune, kidney, skin, neurologic and infectious diseases. Now, the firm says it’s got a blood test for cardiovascular events at an early age.
AMPEL BioSolutions has announced that its genetic precision medicine test for lupus patients could predict heart disease and provide decision support for prophylactic therapies.
AMPEL BioSolutions today announced a genetic precision medicine test for lupus patients that could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies.
It’s a breakthrough discovery for the first-time identifying risk factors in inflammation and the immune system that lead to cardiovascular events. Outside the traditional risk factors of smoking, high fat diet and sedentary lifestyle. Cardio Gene could be a game changer